Nachrichten und Videos - NOVOCURE LTD.

NVCR Investors Have Opportunity to Lead NovoCure Limited Securities Fraud Lawsuit PR Newswire BENSALEM, Pa., Aug. 17, 2023 BENSALEM, Pa. , Aug. 17, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR ). Class Period: January 5, 2023 – June 5, 2023 Lead Plaintiff Deadline: August 18, 2023 Investors suffering...

The Law Offices of Frank R. Cruz reminds investors of the upcoming August 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired NovoCure Limited (“NovoCure” or the “Company”) (NASDAQ: NVCR ) securities between January 5, 2023 and June 5, 2023 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On June 6, 2023, NovoCure announced “positive results” from the clinical...

NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Aug. 17, 2023 NEW YORK , Aug. 17, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of NovoCure investors who were adversely affected by alleged securities fraud between January...

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NovoCure Limited (“NovoCure” or the “Company”) (NASDAQQ: NVCR) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired NovoCure securities between January 5, 2023 and June 5, 2023, both dates inclusive (the “Class Period”). Investors have until...

NVCR IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR PR Newswire NEW YORK, Aug. 16, 2023 NEW YORK , Aug. 16, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NovoCure Limited (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 , both dates inclusive (the "Class Period"), of the important...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NovoCure Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2023 - (NASDAQ: NVCR) PR Newswire NEW YORK, Aug. 16, 2023 NEW YORK , Aug. 16, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NovoCure Limited. Shareholders who purchased shares of NVCR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment...

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against NovoCure Limited (NasdaqGS: NVCR), if they purchased the Company’s securities between January 5, 2023 to June 5, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New...

LOS ANGELES, CA / ACCESSWIRE / August 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NovoCure Limited ("NovoCure" or "the Company") (NASDAQ:NVCR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 5, 2023 and June 5, 2023, inclusive (the...

NVCR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 18, 2023 in the Class Action Filed on Behalf of NovoCure Limited Shareholders PR Newswire NEW YORK, Aug. 15, 2023 NEW YORK , Aug. 15, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NovoCure Limited (NASDAQ: NVCR) alleging that the Company violated federal securities laws. Class Period: January 5, 2023 to June 5, 2023 Lead Plaintiff Deadline:...

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NovoCure Investors of a Lead Plaintiff Deadline of August 18, 2023 PR Newswire NEW YORK, Aug. 14, 2023 NEW YORK , Aug. 14, 2023 /PRNewswire/ -- Attention NovoCure Limited ("NovoCure") (NASDAQ: NVCR) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between January 5, 2023 and June 5, 2023 . If you suffered a loss on your investment in NovoCure, contact us...

LOS ANGELES, CA / ACCESSWIRE / August 13, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NovoCure Limited ("NovoCure" or "the Company") (NASDAQ:NVCR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 5, 2023 and June 5, 2023, inclusive (the...

NOVOCURE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCR PR Newswire NEW ORLEANS, Aug. 11, 2023 NEW ORLEANS , Aug. 11, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against NovoCure Limited (NasdaqGS: NVCR), if they purchased...

NVCR Investors Have Opportunity to Lead NovoCure Limited Securities Fraud Lawsuit PR Newswire LOS ANGELES, Aug. 11, 2023 LOS ANGELES , Aug. 11, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR ). Class Period: January 5, 2023 – June 5, 2023 Lead Plaintiff Deadline: August 18, 2023 If you are a shareholder...

NVCR SHAREHOLDER ALERT: Jakubowitz Law Reminds NovoCure Shareholders of a Lead Plaintiff Deadline of August 18, 2023 PR Newswire NEW YORK, Aug. 11, 2023 NEW YORK , Aug. 11, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NovoCure Limited (NASDAQ: NVCR). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/novocure-class-action-loss-submission-form/?id=43306&from=4 The...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR PR Newswire NEW YORK, Aug. 10, 2023 NEW YORK , Aug. 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether NovoCure and certain of its officers...

NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Aug. 10, 2023 NEW YORK , Aug. 10, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of NovoCure investors who were adversely affected by alleged securities fraud between January...

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NovoCure Limited - NVCR PR Newswire CEDARHURST, N.Y., Aug. 9, 2023 CEDARHURST, N.Y. , Aug. 9, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NovoCure Limited (NasdaqGS: NVCR), if they purchased the Company's securities between January 5, 2023 to June 5, 2023 , inclusive (the "Class Period"). Shareholders have until August 18, 2023 to file lead...

NVCR DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR PR Newswire NEW YORK, Aug. 9, 2023 NEW YORK , Aug. 9, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NovoCure Limited (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 , both dates inclusive (the "Class Period"), of the important August 18, 2023 lead plaintiff...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NovoCure Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2023 - (NASDAQ: NVCR) PR Newswire NEW YORK, Aug. 9, 2023 NEW YORK , Aug. 9, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NovoCure Limited. Shareholders who purchased shares of NVCR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as...

NVCR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 18, 2023 in the Class Action Filed on Behalf of NovoCure Limited Shareholders PR Newswire NEW YORK, Aug. 8, 2023 NEW YORK , Aug. 8, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NovoCure Limited (NASDAQ: NVCR) alleging that the Company violated federal securities laws. Class Period: January 5, 2023 to June 5, 2023 Lead Plaintiff Deadline:...